FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...

Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

A man misdiagnosed with Non-Hodgkin lymphoma, who took cannabis instead of the expensive treatment, leading to a drug debt ...

Two Palestinian pediatric cancer patients arrived in the U.S. for treatment in Washington this week, but renewed fighting in ...

LUND, SE / ACCESS Newswire / March 20, 2025 /BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

After software entrepreneur Marty Thomas survived Stage 4 non-Hodgkin lymphoma, he and wife MariKate started raising chickens ...

Under the terms of the merger agreement, Sanofi will acquire DR-0201 through the acquisition of the Dren Bio affiliate ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about IPHA stock here.

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...